Clinical Trial Update: A Study To Investigate The Effect Of Inhaling A Single Dose Of GW642444M In Asthmatic Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effects of a single inhaled dose of GW642444M in asthmatic patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GW642444M (GW642444M)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED